At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effectiveness of Routine Fetal RhD Genotyping for RhD- Pregnant Women
In Brief
An observational study evaluating Genotyping and Usual prophylaxis for Rhesus Negative Pregnant Women. Completed, enrolled 2,532 participants across 1 site.
Detailed Summary
The study is divided in two sub-studies. The first one is an economical and performance comparison between two antenatal management strategies of RhD negative pregnant women: the first one will comprise non invasive RhD fetal typing during the second trimester of pregnancy (GENIFERH 1 RhD typing group), and the second will be a conventional management, i.e. without RHD fetal typing (GENIFERH 1 control group). The two groups will consist of 13 maternity wards spread over French territory. The second study (GENIFERH 2) is an evaluation of RhD fetal typing diagnostic performance and biological feasibility in routine antenatal practice with development of knew technical support; it will be based on more than 3500 fetal genotypings performed during one year by the five laboratories participating at the two studies.
Study Details
Timeline
Interventions
Whole blood sample
Prophylactic anti-RhD